Tabalumab, referred as atacicept, represents a distinct clinical approach for treating autoimmune diseases. This humanized monoclonal immunoglobulin selectively inhibits B cell stimulatory factor- BAFF, a key protein https://www.targetmol.com/compound/tabalumab